Cargando…
Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
Autores principales: | Valeyrie-Allanore, Laurence, Mockenhaupt, Maja, Sekula, Peggy, Berrehar, François, Ortonne, Nicolas, Assier, Haudrey, Goujon, Colette, Bagot, Martine, Roujeau, Jean-Claude, Bensussan, Armand, Le Gouvello, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127947/ https://www.ncbi.nlm.nih.gov/pubmed/25749121 http://dx.doi.org/10.1186/2045-7022-4-S3-O1 |
Ejemplares similares
-
Usefulness of patch tests in drug adverse reaction induced by tetrazepam and anti-inflammatory drugs
por: Assier, Haudrey, et al.
Publicado: (2014) -
Patch testing in drug cutaneous adverse reactions: value of the extemporaneous preparations
por: Assier, Haudrey, et al.
Publicado: (2014) -
Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?
por: Bouvresse, Sophie, et al.
Publicado: (2012) -
Effects of immunomodulating therapies on mortality in patients with severe cutaneous adverse reactions in comparison with supportive care only: a systematic review
por: Zimmermann, Stefanie, et al.
Publicado: (2014) -
Lymphocyte Transformation Test (LTT) in Allergy to Benznidazole: A Promising Approach
por: Marques-Mejías, M. Andreína, et al.
Publicado: (2019)